Journal of financial reporting & accounting,
Год журнала:
2023,
Номер
unknown
Опубликована: Авг. 26, 2023
Purpose
This
paper
aims
to
investigate
whether
risk-related
information
is
associated
with
a
higher
level
of
performance
disclosure
(PerfD)
in
the
annual
reports
during
Covid-19
pandemic.
Additionally,
this
assesses
if
ownership
structure
plays
moderating
effect
on
relationship
between
RD
and
PerfD.
Design/methodology/approach
A
content
analysis
technique
measure
risk
PerfD
for
72
listed
firms
Abu
Dhabi
stock
exchange
Dubai
financial
market
period
2019–2021.
Findings
The
authors
find
significant
correlation
Indeed,
managers
use
send
signal
about
their
abilities
skills
managing
high-risk
situations
by
disclosing
more
performance-related
accompanying
any
communicated
related
information.
Besides,
our
results
report
that
before
pandemic,
only
government
had
However,
foreign
also
played
an
important
role
improve
firm
transparency.
In
addition,
Big
4
audit
have
effective
quality
control,
auditors
would
play
improving
disclosure.
leveraged
high
may
critical
mitigating
debtholders’
concerns
firm’
ability
manage
pandemic
situation
generate
enough
cash
flows
future
pay
debts.
Originality/value
paper’s
findings
are
highly
relevant
reporting’
users,
mainly
shareholders,
as
they
will
be
aware
management
behaviors
crisis
how
engaged
useful
regulators
reinforce
maintain
good
reporting,
especially
circumstances.
benefit
from
through
optimization
(dispersed
ownership),
which
helps
promote
transparency
Journal of Medical Virology,
Год журнала:
2023,
Номер
95(8)
Опубликована: Июль 29, 2023
Abstract
Severe
acute
respiratory
syndrome
coronavirus‐2
(SARS‐CoV‐2)
damages
multiple
organs,
including
the
thyroid,
by
direct
invasion
and
cell
entry
via
angiotensin‐converting
enzyme
2
or
indirectly
promoting
excessive
inflammation
in
body.
The
immune
system
is
a
critical
factor
antiviral
immunity
disease
progression.
In
context
of
SARS‐CoV‐2
infection,
may
become
overly
activated,
resulting
shift
from
regulatory
to
effector
responses,
which
subsequently
promote
development
progression
autoimmune
diseases.
incidence
thyroid
diseases,
such
as
subacute
thyroiditis,
Graves'
disease,
Hashimoto's
increases
individuals
with
COVID‐19
infection.
This
phenomenon
be
attributed
aberrant
responses
T‐cell
subtypes,
presence
autoantibodies,
impaired
function,
production
inflammatory
cytokines,
namely
interleukin
(IL)‐6,
IL‐1β,
interferon‐γ,
tumor
necrosis
factor‐α.
Therefore,
insights
into
involved
according
can
help
identify
potential
therapeutic
approaches
guide
effective
interventions
alleviate
patients'
symptoms.
Frontiers in Endocrinology,
Год журнала:
2022,
Номер
13
Опубликована: Ноя. 10, 2022
Purpose
The
purpose
of
this
study
was
to
describe
the
current
knowledge
on
potential
endocrine
adverse
effects
post-COVID-19
vaccines.
Methods
A
PubMed/MEDLINE,
Web
Science,
and
Scopus
research
performed.
Case
reports,
case
series,
original
studies,
reviews
written
in
English
published
online
up
31
July
2022
were
selected
reviewed.
final
reference
list
defined
based
relevance
each
paper
scope
review.
Results
available
data
showed
that
side
are
generally
rare
with
favorable
outcome,
being
thyroid
disorders
most
common.
Conversely,
type
1
diabetes
mellitus
rare;
adrenal
pituitary
events
even
anecdotal.
Finally,
clinical
studies
suggest
no
impact
female
reproductive
system
male
couple
fertility.
Conclusion
Overall,
these
show
that,
after
2
years
COVID-19
vaccines,
is
not
heavily
threatened.
BMC Endocrine Disorders,
Год журнала:
2023,
Номер
23(1)
Опубликована: Июнь 15, 2023
Abstract
Background
Autoimmune/inflammatory
syndrome
induced
by
adjuvants
(ASIA)
is
characterized
immune
system
dysregulation
after
exposure
to
adjuvants,
such
as
aluminum.
Although
cases
of
autoimmune
thyroid
diseases
caused
ASIA
have
been
reported,
Graves'
disease
one
the
rarer
diseases.
There
are
some
reports
that
vaccines
against
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2)
cause
ASIA.
Here,
we
describe
a
case
Graves’
following
SARS-CoV-2
vaccination
and
review
literature.
Case
presentation
A
41-year-old
woman
was
admitted
our
hospital
because
palpitations
fatigue.
Two
weeks
receiving
second
vaccine
(BNT162b2,
Coronavirus
Modified
Uridine
messenger
RNA
(mRNA)
Vaccine,
Pfizer),
she
developed
fatigue
gradually
worsened.
On
admission,
exhibited
thyrotoxicosis
(thyroid-stimulating
hormone
(TSH)
<
0.01
mIU/L
(0.08–0.54),
free
triiodothyronine
(FT3)
33.2
pmol/L
(3.8–6.3),
thyroxine
(FT4)
72.1
(11.6–19.3))
associated
with
atrial
fibrillation.
TSH
receptor
antibody
(TRAb)
positive
(TRAb
5.0
IU/L
(<
2.0)),
99m
Tc
scintigraphy
showed
diffuse
uptake
in
gland,
suggesting
this
disease.
Thiamazole
prescribed
correct
her
condition,
soon
treatment
initiated,
symptoms
levels
were
significantly
reduced.
Conclusions
This
report
reinforces
potential
correlation
between
affecting
mRNA
vaccines.
The
clinical
course
suggests
it
essential
consider
possibility
developing
ASIA,
disease,
vaccine.
Frontiers in Endocrinology,
Год журнала:
2022,
Номер
13
Опубликована: Сен. 27, 2022
The
newly
developed
COVID-19
vaccines
have
established
a
safe
profile,
yet
some
individuals
experience
wide
range
of
adverse
events.
Recently,
thyroid
dysfunction,
including
Graves'
disease,
has
been
observed
after
administration
different
vaccines,
although
causality
remains
matter
debate.
aim
this
systematic
review
was
to
examine
the
available
literature
and
provide
an
overview
reported
cases
disease
following
vaccination.
We
identified
21
eligible
articles
which
included
57
patients
with
Fourteen
participants
were
males
(25%,
14/57)
43
(75%,
44/57)
females
mean
age
44.3
years.
most
common
presenting
symptom
palpitations
(63%,
27/43)
followed
by
weight
loss
(35%,
15/43).
majority
received
thionamides
(47%,
25/53).
clinical
status
treatment
provided
for
37
it
improved
in
them
(84%,
31/37).
is
possibly
condition
clinicians
may
expect
encounter
receiving
vaccines.
While
above
event
rare,
considering
scarcity
data
scientific
literature,
not
confirmed,
increased
awareness
early
recognition
disorder
are
important
optimal
management
these
patients.
Vaccines,
Год журнала:
2022,
Номер
10(9), С. 1445 - 1445
Опубликована: Сен. 1, 2022
(1)
Background:
Autoimmune
diseases,
including
autoimmune
endocrine
diseases
(AIED),
are
thought
to
develop
following
environmental
exposure
in
patients
with
genetic
predisposition.
The
vaccines
against
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
could
represent
a
new
trigger
for
AIED,
Graves’
disease
(GD).
(2)
Methods:
We
performed
literature
search
of
MEDLINE/PubMed
databases
regarding
thyroid
dysfunction
after
SARS-CoV-2
vaccination
since
1
January
2020
31
July
2022,
considering
only
cases
thyrotoxicosis
that
meet
the
2016
American
Thyroid
Association
guidelines
criteria
diagnosis
GD
and
arising
administration
anti-SARS-CoV-2
vaccine,
regardless
number
doses.
(3)
Results:
A
total
27
articles
were
identified,
consisting
case
reports
or
series,
which
24
describe
appearance
48
diagnoses
12
recurrences
3
papers
instead
report
relapse
vaccination.
(4)
Conclusions:
physicians
should
be
aware
possibility
developing
other
sequelae
Regardless
underlying
pathogenetic
mechanisms
(autoimmune/inflammatory
induced
by
adjuvants
(ASIA
syndrome),
cytokines
induction,
molecular
mimicry,
cross-reactivity),
an
individual
predisposition
seems
decisive
their
development.
